Affordable Access

deepdyve-link
Publisher Website

[Highlights of the guidelines of prevention and treatment for hepatitis C (2019 version)].

Authors
  • Rao, H Y1
  • Duan, Z P2
  • Wang, G Q3
  • Wei, L4
  • 1 Peking University People's Hospital, Peking University Hepatology Institute, Beijing 100044, China. , (China)
  • 2 Difficult & Complicated Liver Diseases and Artificial Liver Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China. , (China)
  • 3 Department of Infectious Diseases and Center for Liver Diseases, Peking University First Hospital; Department of Infectious Diseases and Liver, Diseases, Peking University Internatianal Hospital, Beijing 100034, China. , (China)
  • 4 Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China. , (China)
Type
Published Article
Journal
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Publication Date
Feb 20, 2020
Volume
28
Issue
2
Pages
129–132
Identifiers
DOI: 10.3760/cma.j.issn.1007-3418.2020.02.005
PMID: 32164062
Source
Medline
Keywords
Language
Chinese
License
Unknown

Abstract

比较了《丙型肝炎防治指南 (2019年版)》和以往《丙型肝炎指南》的更新要点。介绍了新的术语。重点强调了世界卫生组织提出的目标——2030年消除病毒性肝炎的公共卫生威胁。在预防部分,将对高危人群进行丙型肝炎病毒感染筛查作为预防的首要手段,强调治疗就是预防。在治疗方面,首先推荐无干扰素的泛基因型方案。还介绍了我国自主研发的直接抗病毒药物,介绍了多个特殊人群的抗病毒治疗方案,包括肝硬化失代偿、慢性肾脏疾病、儿童和青少年、合并慢性肾脏损伤、肝移植前后、合并HBV感染、治疗失败人群、急性丙型肝炎等。介绍了简化的治疗监测流程,特别提到在我国西南地区流行的基因3型。.

Report this publication

Statistics

Seen <100 times